2024

MedGenome Appoints Industry Veterans Felix Olale, M.D., Ph.D., as CEO and Jennifer Rose as Chief Commercial Officer to Lead U.S. Expansion

New Leadership Team Poised to Accelerate Growth, Drive Innovation in Precision Medicine and Advance Multiomics Solutions FOSTER CITY, Calif.–(BUSINESS WIRE)–MedGenome, a global leader in multiomics and precision medicine, today announced the appointment of two distinguished executives to lead its U.S. operations. Felix Olale, M.D., Ph.D., has been named President and Chief Executive Officer, and Jennifer […]

MedGenome boosts omic insights capabilities as the first commercial provider in the San Francisco Bay Area of California to bring PacBio Revio in-house with full service capability

FOSTER CITY, Calif., July 18, 2024 /PRNewswire/ — MedGenome, a leading provider of multiomics solutions, today announced the acquisition of a PacBio Revio sequencing system. This latest addition to MedGenome’s technology portfolio will significantly bolster their long-read sequencing capabilities, enabling researchers to delve deeper into the complexities of the genome and advance scientific discoveries. PacBio’s

MedGenome announces de novo Genome Assembly and Annotation Grant winners for 2024

SAN FRANCISCO, May 2, 2024 /PRNewswire/ — MedGenome, a global partner for comprehensive multiomics solutions, in collaboration with PacBio, is pleased to announce Dr. Lauren Esposito of the California Academy of Sciences as the recipient of the ‘2024 de novo genome assembly and annotation grant‘. Dr. Lauren Esposito, Curator and Schlinger Chair of Arachnology at